China Food and Drug Administration (CFDA) recently released the 2013 Drug Review Annual Report. The Annual Report describes the general situation of drug registration acceptance, review and approval in 2013, and analyzes the data of acceptance and review in 2013 and the review timeline for chemical drugs, traditional Chinese medicines and biological products respectively.